SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
7526509
Source:
http://linkedlifedata.com/resource/pubmed/id/7526509
Search
Subject
(
54
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0087111
,
umls-concept:C0139797
,
umls-concept:C0376358
,
umls-concept:C0449258
,
umls-concept:C0458083
,
umls-concept:C1516213
pubmed:issue
4
pubmed:dateCreated
1994-12-15
pubmed:abstractText
The therapeutic potential of R75251, a ketoconazole derivative which has shown marked antitumor activity in animals and in men, was investigated in 16 patients with advanced prostatic cancer progressing after one or more lines of hormone therapy.
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/0111356
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Androgen Antagonists
,
http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents
,
http://linkedlifedata.com/resource/pubmed/chemical/Hydrocortisone
,
http://linkedlifedata.com/resource/pubmed/chemical/Imidazoles
,
http://linkedlifedata.com/resource/pubmed/chemical/Prostate-Specific Antigen
,
http://linkedlifedata.com/resource/pubmed/chemical/Testosterone
,
http://linkedlifedata.com/resource/pubmed/chemical/liarozole
pubmed:status
MEDLINE
pubmed:month
Aug
pubmed:issn
0300-8916
pubmed:author
pubmed-author:BoccardiLL
,
pubmed-author:BoneKK
,
pubmed-author:CannataDD
,
pubmed-author:CorteseAA
,
pubmed-author:GuarneriDD
,
pubmed-author:OnetoFF
pubmed:issnType
Print
pubmed:day
31
pubmed:volume
80
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
276-9
pubmed:dateRevised
2008-12-12
pubmed:meshHeading
pubmed-meshheading:7526509-Aged
,
pubmed-meshheading:7526509-Androgen Antagonists
,
pubmed-meshheading:7526509-Antineoplastic Agents
,
pubmed-meshheading:7526509-Drug Administration Schedule
,
pubmed-meshheading:7526509-Humans
,
pubmed-meshheading:7526509-Hydrocortisone
,
pubmed-meshheading:7526509-Imidazoles
,
pubmed-meshheading:7526509-Male
,
pubmed-meshheading:7526509-Middle Aged
,
pubmed-meshheading:7526509-Prostate-Specific Antigen
,
pubmed-meshheading:7526509-Prostatic Neoplasms
,
pubmed-meshheading:7526509-Testosterone
,
pubmed-meshheading:7526509-Treatment Outcome
pubmed:year
1994
pubmed:articleTitle
R75251 in prostate cancer patients in progression after first-line hormonal treatment.
pubmed:affiliation
Department of Medical Oncology II, National Institute for Cancer Research, Genoa, Italy.
pubmed:publicationType
Journal Article
,
Clinical Trial